Product Information

TOPIRAMATE ER 100 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $10.2003 per EA under NDC 43598094130. Its NADAC has been published 26 times since Feb 25, 2026.

FDA first approved this application on Nov 17, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE ER 100 MG CAPSULE

Topiramate
$10.2003per EA

Strength

100 mg/1

NDC

43598094130

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA217231

FDA Approved

11/17/2023

TE Code

AB1

On Market Since

2/1/2026

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 100 MG CAPSULE has been published 26 times since Feb 25, 2026, and over the history we have for it it has declined 18.0%. The table below summarizes its recorded NADAC range and movement.

Current price$10.2003 per EA
All-time high$12.4431 (Mar 11, 2026)
All-time low$10.2003 (Aug 19, 2026)
52-week high$12.4431
52-week low$10.2003
Median price$11.5580
Average price$11.4463
Largest weekly change-7.2% (Jun 17, 2026)
Weeks tracked26
Tracking sinceFeb 25, 2026

Price History

1W

-2.9%

1M

-2.9%

3M

-12.0%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-18.0%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 100 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $10.2003 per EA (NDC 43598094130), effective Aug 19, 2026.

How has the price of TOPIRAMATE ER 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 100 MG CAPSULE has declined 18.0%. It has been tracked across 26 weekly CMS publications since Feb 25, 2026.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 100 MG CAPSULE?

Since Feb 25, 2026, the NADAC for TOPIRAMATE ER 100 MG CAPSULE has ranged from a low of $10.2003 (Aug 19, 2026) to a high of $12.4431 (Mar 11, 2026), with a median of $11.5580 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 100 MG CAPSULE?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 100 MG SPRINK CAP, is $5.3819 per EA — about 47% below TOPIRAMATE ER 100 MG CAPSULE.

Who manufactures TOPIRAMATE ER 100 MG CAPSULE?

TOPIRAMATE ER 100 MG CAPSULE (NDC 43598094130) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.